Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000919574-25-007115·Avidity Partners Management LP
Schedule 13D ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock, $0.001 par value · CUSIP: 252828108
Event date: 2025-11-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avidity Partners Management LPReported CIK 0001791827
Shares: 2,104,184.00 · Class: 4.9%
- Avidity Partners Management (GP) LLC
Shares: 2,104,184.00 · Class: 4.9%
- Avidity Capital Partners Fund (GP) LP
Shares: 2,104,184.00 · Class: 4.9%
- Avidity Capital Partners (GP) LLC
Shares: 2,104,184.00 · Class: 4.9%
- Avidity Private Master Fund I LP
Shares: 1,899,593.00 · Class: 4.4%
- Michael Gregory
Shares: 2,104,184.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-007115
- Form type
- SCHEDULE 13D/A
- Filer
- Avidity Partners Management LP
- CIK
- CIK 1791827
- Filed
- Nov 19, 2025
- Reporting period
- Nov 17, 2025
- Description
- Schedule 13D beneficial ownership